muricholic acid has been researched along with glucagon-like peptide 1 in 1 studies
| Studies (muricholic acid) | Trials (muricholic acid) | Recent Studies (post-2010) (muricholic acid) | Studies (glucagon-like peptide 1) | Trials (glucagon-like peptide 1) | Recent Studies (post-2010) (glucagon-like peptide 1) |
|---|---|---|---|---|---|
| 119 | 1 | 36 | 9,484 | 1,208 | 6,374 |
| Protein | Taxonomy | muricholic acid (IC50) | glucagon-like peptide 1 (IC50) |
|---|---|---|---|
| Glucagon-like peptide 1 receptor | Homo sapiens (human) | 0.0051 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, Y; Chen, T; Dong, B; Hu, C; Jia, W; Jiang, C; Jiang, R; Kuang, J; Lan, K; Li, D; Li, H; Li, M; Lu, A; Rajani, C; Ren, Z; Sun, D; Wang, S; Wang, X; Wu, J; Wu, Q; Xia, J; Xie, G; Zhao, A; Zhao, M; Zheng, X | 1 |
1 other study(ies) available for muricholic acid and glucagon-like peptide 1
| Article | Year |
|---|---|
Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism.
Topics: Animals; Blood Glucose; Cell Line; Cholic Acids; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Humans; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Signal Transduction; Swine | 2021 |